Advertisement

Search Results

Advertisement



Your search for Jo Cavallo matches 6 pages

Showing 1 - 6


issues in oncology
cost of care

2018 Quality Care: Older Patients With Advanced Cancer Experiencing Financial Difficulties Have Worse Quality of Life and Mental Health

Older patients with advanced cancer experiencing financial toxicity due to the cost of their treatment have higher rates of severe anxiety and depression and poorer quality of life than patients who do not experience financial hardship. In addition, for those patients having financial difficulty,...

breast cancer
gynecologic cancers
cost of care

Population-Based Screening for Breast and Ovarian Cancer Genetic Mutations Appears Cost-Effective

The cost-effectiveness of population-based panel testing for the known high- and moderate-penetrance ovarian and breast cancer mutations, including BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, and PALB2, was not known. Now, a study evaluating the cost-effectiveness of screening the general population for...

issues in oncology
cost of care

Studies Find Disparity in Life Expectancy Widening Between Wealthy and Poor Americans

To better understand the conditions and mechanisms driving health disparities in the United States, The Lancet partnered with physicians and public health researchers from the City University of New York, Harvard Medical School, Cornell University, Yale School of Medicine, and the New York...

issues in oncology
survivorship
cost of care

AACR’s Cancer Progress Report Details Major Advances in Cancer and Rising Costs of Treatment

The American Association for Cancer Research (AACR) 2015 Cancer Progress Report highlighted the accelerated pace of the number of U.S. Food and Drug Administration (FDA)-approved targeted therapies over the past 5 years, which reached 52 this year; the dramatic increase in the 5-year survival rate...

issues in oncology
issues in oncology
cost of care

ASCO Publishes Conceptual Framework to Assess the Value of New Cancer Treatment Options

In a press conference today, ASCO detailed the contents of the initial version of a conceptual framework for assessing the value of new cancer treatment options based on the treatment’s clinical benefit, side effects, and cost. Other important measures, such as quality of life and...

cost of care

Study Finds Oncology Drug Pricing Models ‘Not Rational’

A statistical analysis of 51 oncology drugs approved by the U.S. Food and Drug Administration (FDA) between January 1, 2009, and December 31, 2013, has found that cancer drug prices are rising faster than the prices in other sectors of health care and that the high cost of the drugs is not...

Advertisement

Advertisement



Advertisement